Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
Yooli has sold a minority stake to La Poste Santé & Autonomie and La Poste Ventures
Yooli has sold a minority stake to La Poste Ventures, the investment fund of La Poste Santé & Autonomie, following a process conducted in France and internationally. The entry of La Poste Ventures, a recognized player in the healthcare sector, reflects a shared vision to support the digital transformation of healthcare institutions through pragmatic, secure and user-centric solutions focused on the needs of healthcare professionals and patients.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more
Jan De Backer
CEO, Fluidda NV
Read more
Celebrity-backed rehab center joins UK’s expanding addiction treatment network
DEAL FLASH: The Providence Projects, one of the UK’s leading providers of affordable private alcohol and drug rehabilitation services, has been acquired by UKAT Group, a network of rehabilitation clinics across the UK.
Learn more
Talk to us
